Skip to main content

Top TTAI Holding Novo Nordisk Nearly Doubles Free Cash Flow in 2022

Novo Nordisk nearly doubled its free cash flow in 2022 from 2021. The Danish pharmaceutical company announced at the beginning of the month that its free cash flow last year was 57.4 billion Danish kroner ($8.37 billion), compared to 29.3 billion Danish kroner in 2021. This free cash flow supported “the strategic aspiration to deliver [...] The post Top TTAI Holding Novo Nordisk Nearly Doubles Free Cash Flow in 2022 appeared first on ETF Trends .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.